Cargando…

Plasma pharmacokinetics after combined therapy of gemcitabine and oral S-1 for unresectable pancreatic cancer

BACKGROUND: The combination of gemcitabine (GEM) and S-1, an oral 5-fluorouracil (5-FU) derivative, has been shown to be a promising regimen for patients with unresectable pancreatic cancer. METHODS: Six patients with advanced pancreatic cancer were enrolled in this pharmacokinetics (PK) study. Thes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakata, Bunzo, Amano, Ryosuke, Nakao, Shigetomi, Tamura, Tatsuro, Shinto, Osamu, Hirakawa, Toshiki, Okita, Yoshihiro, Yamada, Nobuya, Hirakawa, Kosei
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2838818/ https://www.ncbi.nlm.nih.gov/pubmed/20181235 http://dx.doi.org/10.1186/1756-9966-29-15

Ejemplares similares

Prognostic predictive values of gemcitabine sensitivity-related gene products for unresectable or recurrent biliary tract cancer treated with gemcitabine alone
por: Murata, Akihiro, et al.
Publicado: (2013)

IGF-1 receptor and IGF binding protein-3 might predict prognosis of patients with resectable pancreatic cancer
por: Hirakawa, Toshiki, et al.
Publicado: (2013)

Gemcitabine sensitivity-related mRNA expression in endoscopic ultrasound-guided fine-needle aspiration biopsy of unresectable pancreatic cancer
por: Ashida, Reiko, et al.
Publicado: (2009)

Clinical and pathological features of five-year survivors after pancreatectomy for pancreatic adenocarcinoma
por: Kimura, Kenjiro, et al.
Publicado: (2014)

Preoperative predictors for early recurrence of resectable pancreatic cancer
por: Nishio, Kohei, et al.
Publicado: (2017)

Salvage surgery after chemotherapy with S-1 plus cisplatin for α-fetoprotein-producing gastric cancer with a portal vein tumor thrombus: a case report
por: Nakao, Shigetomi, et al.
Publicado: (2015)

RNA interference suppression of mucin 5AC (MUC5AC) reduces the adhesive and invasive capacity of human pancreatic cancer cells
por: Yamazoe, Sadaaki, et al.
Publicado: (2010)

Doublecortin and CaM kinase-like-1 as an independent prognostic factor in patients with resected pancreatic carcinoma
por: Nishio, Kohei, et al.
Publicado: (2017)

Pancreatic Fibroblasts Stimulate the Motility of Pancreatic Cancer Cells through IGF1/IGF1R Signaling under Hypoxia
por: Hirakawa, Toshiki, et al.
Publicado: (2016)

Establishment and characterization of new cell lines of anaplastic pancreatic cancer, which is a rare malignancy: OCUP-A1 and OCUP-A2
por: Miura, Kotaro, et al.
Publicado: (2016)

The prognostic significance of the advanced lung cancer inflammation index in patients with unresectable metastatic colorectal cancer: a retrospective study
por: Shibutani, Masatsune, et al.
Publicado: (2019)

Hypoxia Stimulates the EMT of Gastric Cancer Cells through Autocrine TGFβ Signaling
por: Matsuoka, Junko, et al.
Publicado: (2013)

The pretreatment Controlling Nutritional Status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective study
por: Toyokawa, Takahiro, et al.
Publicado: (2016)

Comparison of the prognostic impact and combination of preoperative inflammation-based and/or nutritional markers in patients with stage II gastric cancer
por: Toyokawa, Takahiro, et al.
Publicado: (2018)

Phase II trial of nafamostat mesilate/gemcitabin/S-1 for unresectable pancreatic cancer
por: Uwagawa, Tadashi, et al.
Publicado: (2022)

Significance of tumor‐infiltrating lymphocytes before and after neoadjuvant therapy for rectal cancer
por: Matsutani, Shinji, et al.
Publicado: (2018)

The peripheral monocyte count is associated with the density of tumor-associated macrophages in the tumor microenvironment of colorectal cancer: a retrospective study
por: Shibutani, Masatsune, et al.
Publicado: (2017)

Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer
por: Melisi, Davide, et al.
Publicado: (2018)

High-intensity focused ultrasound therapy in combination with gemcitabine for unresectable pancreatic carcinoma
por: Lv, Wei, et al.
Publicado: (2016)

Comparing the Efficacy and Safety of Gemcitabine plus Nab-Paclitaxel versus Gemcitabine Alone in Older Adults with Unresectable Pancreatic Cancer
por: Kobayashi, Satoshi, et al.
Publicado: (2022)

Phase II study of chemoradiotherapy combined with gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic ductal adenocarcinoma (NUPAT 05 Trial): study protocol for a single arm phase II study
por: Takano, Nao, et al.
Publicado: (2019)

The pretreatment albumin to globulin ratio predicts chemotherapeutic outcomes in patients with unresectable metastatic colorectal cancer
por: Shibutani, Masatsune, et al.
Publicado: (2015)

Conversion surgery with gemcitabine plus nab-paclitaxel for locally advanced unresectable pancreatic cancer: A case report
por: Okura, Ryosuke, et al.
Publicado: (2018)

The significance of the C-reactive protein to albumin ratio as a marker for predicting survival and monitoring chemotherapeutic effectiveness in patients with unresectable metastatic colorectal cancer
por: Shibutani, Masatsune, et al.
Publicado: (2016)

Clinical significance of coexisting histological diffuse type in stage II/III gastric cancer
por: Tanaka, Hiroaki, et al.
Publicado: (2021)

In vivo and in vitro Interactions between Human Colon Carcinoma Cells and Hepatic Stellate Cells
por: Shimizu, Sadatoshi, et al.
Publicado: (2000)

Long-term survival with complete remission after hepatic arterial infusion chemotherapy for liver metastasis from gastric cancer: a case report
por: Toyokawa, Takahiro, et al.
Publicado: (2015)

Treatment Outcomes and Prognostic Factors of Gemcitabine Plus Nab-Paclitaxel as Second-Line Chemotherapy after Modified FOLFIRINOX in Unresectable Pancreatic Cancer
por: Mie, Takafumi, et al.
Publicado: (2023)

A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer
por: Friess, Helmut, et al.
Publicado: (2006)

Neutrophils in primary gastric tumors are correlated with neutrophil infiltration in tumor-draining lymph nodes and the systemic inflammatory response
por: Hiramatsu, Soichiro, et al.
Publicado: (2018)

Immunological potential of tertiary lymphoid structures surrounding the primary tumor in gastric cancer
por: Yamakoshi, Yoshihito, et al.
Publicado: (2020)

Novel Therapeutic Method for Unresectable Pancreatic Cancer—The Impact of the Long-Term Research in Therapeutic Effect of High-Intensity Focused Ultrasound (HIFU) Therapy
por: Sofuni, Atsushi, et al.
Publicado: (2021)

Giant duodenal ulcers after neurosurgery for brainstem tumors that required reoperation for gastric disconnection: a report of two cases
por: Nobori, Chihoko, et al.
Publicado: (2016)

Pure Mucinous Breast Carcinoma with Micropapillary Pattern (MUMPC): A Case Report
por: Asano, Yuka, et al.
Publicado: (2019)

Adenoid Cystic Carcinoma of the Breast: A Case Report
por: Kashiwagi, Shinichiro, et al.
Publicado: (2019)

Human equilibrative nucleoside transporter 1 and Notch3 can predict gemcitabine effects in patients with unresectable pancreatic cancer
por: Eto, K, et al.
Publicado: (2013)

The Survival Benefit of Chemoradiotherapy following Induction Chemotherapy with Gemcitabine Plus Nab-Paclitaxel for Unresectable Locally Advanced Pancreatic Cancer
por: Takada, Ryoji, et al.
Publicado: (2021)

Prognostic factors in conversion surgery following nab‐paclitaxel with gemcitabine and subsequent chemoradiotherapy for unresectable locally advanced pancreatic cancer: Results of a dual‐center study
por: Igarashi, Takamichi, et al.
Publicado: (2022)

A case of bowel perforation due to traumatic hernia at a pelvic fracture site: a case report and review of the literature
por: Tanaka, Ryota, et al.
Publicado: (2017)

Early skeletal muscle mass decline is a prognostic factor in patients receiving gemcitabine plus nab-paclitaxel for unresectable pancreatic cancer: a retrospective observational study
por: Suzuki, Yukari, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8oiiitlunbo3l856d0o7jpp0k2